Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination of Checkpoint Inhibitor and Radiotherapy for Recurrent Gastric Cancer After Initial Treatment With Standard Therapy (CIRCUIT).

NCT03453164 is registered in ClinicalTrials.gov with Fukushima Medical University as lead sponsor.

NCT NCT03453164
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03453164 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination of Checkpoint Inhibitor and Radiotherapy for Recurrent Gastric Cancer After Initial Treatment With Standard Therapy (CIRCUIT).
Lead sponsor
Fukushima Medical University
Phase
Phase 1/2
Overall status
Completed
Start date
March 28, 2018
Completion date
January 31, 2021
Enrollment
41 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer